74 completed, 18 unknown, 8 active not recruiting, 5 terminated. 42 Phase 3, 25 Phase 2, 15 Phase 1, 10 Not applicable, 5 Phase 4.
Follow Condylomata Acuminata: new trials by email Literature Review of Condylomata Acuminata trials Research Report on Condylomata Acuminata
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel Geniwa gel, Placebo gel - HPV (Human Papillomavirus)-Associated, Genital Warts | Phase 2 | Recruiting | KTH Biopharma | 70 | 2026-07-16 | 2026-10-20 |
| Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts Topical 25% podophyllin, Cryotherapy - Anogenital Human Papilloma Virus Infection | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 96 | 2025-06-29 | 2025-05-13 |
| A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.coli), Aluminum Adjuvant - Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia | Phase 3 | Active not recruiting | Xiamen University | 9300 | 2025-04-11 | 2025-07-31 |
| To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo - HPV Infection, HPV-Related Carcinoma | Phase 2 | Recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 330 | 2025-01-15 | 2025-12-17 |
| Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure Human papillomavirus 9-valent vaccine, Recombinant - HPV Infection, Cervical Cancer | Phase 2 | Not yet recruiting | National Institute of Hygiene and Epidemiology, Vietnam | 300 | 2024-12-14 | 2024-11-08 |
| Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient Injection of protein purified derivative - Anogenital Warts, HIV Infection | Phase 2 / Phase 3 | Unknown | Universitas Padjadjaran | 30 | 2024-09-15 | 2024-09-19 |
| A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years Placebo, 15-valent recombinant human papillomavirus vaccine (Hansenulapolymorpha) - HPV Infection, HPV-Related Carcinoma | Phase 1 | Unknown | Shanghai Bovax Biotechnology Co., Ltd. | 72 | 2024-08-03 | 2025-01-06 |
| A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Genital Wart, Penile Cancer | Phase 3 | Active not recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 9000 | 2024-07-11 | 2024-12-12 |
| Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata Peginterferon α-2b injection, CO2 laser - Condylomata Acuminata | Not applicable | Unknown | Zhangyu Bu | 30 | 2024-07-01 | 2024-06-20 |
| Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study CUSA (Cavitronic Ultrasonic Surgical Aspirator) - Vulvar Intraepithelial Neoplasia, Condylomata Acuminata | Completed | Integra LifeSciences Corporation | 56 | 2024-02-23 | 2024-09-19 | |
| Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli), Gardasil®9 - Cervical Cancer, Condylomata Acuminata | Active not recruiting | Xiamen University | 392 | 2023-12-30 | 2025-07-31 | |
| A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Cervical Cancer, Genital Wart | Phase 3 | Terminated | Shanghai Bovax Biotechnology Co., Ltd. | 3131 | 2022-12-09 | 2023-07-21 |
| Topical Ethanol Extract (Piper Crocatum) for Anogenital Warts Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical - Anogenital Wart | Not applicable | Unknown | Hasanuddin University | 100 | 2022-11-30 | 2022-11-21 |
| Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old Placebo among 18-45 yrs, Placebo among 9-17 yrs - Penile Cancer, Anal Cancer | Phase 1 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 90 | 2022-09-23 | 2024-04-17 |
| Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 Zerun HPV-9, GARDASIL ®9 - Cervical Cancer, Genital Wart | Phase 3 | Unknown | Shanghai Zerun Biotechnology Co.,Ltd | 1200 | 2022-09-01 | 2022-10-28 |
| The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue Curcumin Oral Capsule, Trichloroacetic acid, Blood sample collection - Anogenital Wart | Phase 2 / Phase 3 | Completed | Universitas Indonesia | 78 | 2022-08-16 | 2024-02-28 |
| Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts the Quadrivalent Vaccine (Gardasil) - Human Papilloma Virus, Anogenital Wart | Not applicable | Unknown | Zagazig University | 58 | 2022-06-01 | 2023-03-09 |
| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine HPV Infections, Cervical Cancer Stage IIa | Recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 600 | 2022-05-14 | 2024-04-17 | |
| Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053) 9vHPV vaccine - Genital Warts | Phase 3 | Active not recruiting | Merck Sharp & Dohme LLC | 1590 | 2022-05-07 | 2023-01-19 |
| Intralesional HPV Vaccine for Condylomata nonavalent human papillomavirus vaccine - Human Papilloma Virus, Warts | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 2 | 2022-04-15 | 2025-10-02 |
Showing 20 of 112. Sign in to see all of them.
Uterine Cervical Neoplasms (44) · Papillomavirus Infections (33) · Vaginal Neoplasms (18) · Vulvar Neoplasms (18) · Anus Neoplasms (9) · Sexually Transmitted Diseases (6) · Warts (5) · Uterine Cervical Dysplasia (4) · Virus Diseases (4) · HIV Infections (3) · Penile Neoplasms (3) · Recurrence (3) · Acquired Immunodeficiency Syndrome (2) · Oropharyngeal Neoplasms (2)
Communicable Diseases (112) · Disease Attributes (112) · Genital Diseases (112) · Infections (112) · Pathologic Processes (112) · Pathological Conditions, Signs and Symptoms (112) · Skin and Connective Tissue Diseases (112) · Urogenital Diseases (112) · DNA Virus Infections (111) · Tumor Virus Infections (111) · Sexually Transmitted Diseases, Viral (110) · Skin Diseases (110) · Skin Diseases, Infectious (110) · Skin Diseases, Viral (110) · Virus Diseases (108)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (15) · Vaccines, Synthetic (10) · Papillomavirus Vaccines (7) · Vaccines (5) · Imiquimod (4) · Gels (3) · Trichloroacetic Acid (3) · Cantharidin (2) · Cryotherapy (2) · Duration of Therapy (2) · Ethanol (2) · Human Papillomavirus Recombinant Vaccine nonavalent (2) · Podophyllin (2) · green tea extract polyphenone E (2) · human papillomavirus vaccine, L1 type 16, 18 (2)
Merck Sharp & Dohme LLC (19) · Shanghai Bovax Biotechnology Co., Ltd. (12) · Xiamen University (7) · Beijing Health Guard Biotechnology, Inc (3) · Jun Zhang (3) · MediGene (3) · Assiut University (2) · Duke University (2) · Gilead Sciences (2) · Graceway Pharmaceuticals, LLC (2) · Regenstrief Institute, Inc. (2) · Shanghai Zerun Biotechnology Co.,Ltd (2) · University of British Columbia (2) · Zagazig University (2) · Anaconda Pharma (1)
China (30) · United States (16) · Argentina (5) · Germany (4) · Canada (3) · Chile (3) · Taiwan (3) · Vietnam (3) · Austria (2) · Colombia (2) · Egypt (2) · France (2) · Indonesia (2) · Italy (2) · Peru (2)
Jun Zhang, Master (5) · Jun Zhang, master (4) · Yongjiang Liu, Bachelor (3) · Emmanuel B Walter, MD (2) · Feng-cai Zhu, master (2) · Gregory D Zimet, PhD (2) · Jason Wu, MD (2) · Ting Huang (2) · Yue-Mei Hu, Bachelor (2) · Anna Novotney-Barry (1) · Ayan Kusari, MD (1) · Ayman Marei, MD, PhD (1) · Bo Huang, PH.D, MD (1)
PMID 32184277, PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 27422279, PMID 30982556, PMID 41166720, PMID 20949623, PMID 21471141, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23632723, PMID 29074187, PMID 29211620, PMID 29995724, PMID 33326342, PMID 10693114, PMID 10782451, PMID 11238198, PMID 12807939, PMID 13519856, PMID 15215482, PMID 15897380, PMID 16973081, PMID 18042215, PMID 18164106, PMID 18433504, PMID 18515521, PMID 19116707, PMID 19170869, PMID 19453788, PMID 19505910, PMID 20647284, PMID 20706119, PMID 21248158, PMID 21288094, PMID 21300618, PMID 21307649, PMID 21491420, PMID 22029979, PMID 22306855, PMID 22469863, PMID 23336207, PMID 23486550, PMID 23831322, PMID 24055350, PMID 24643186, PMID 25227629
2004 (2), 2017 (1)